These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20556424)

  • 1. Biologics in children's autoimmune disorders: efficacy and safety.
    Breda L; Del Torto M; De Sanctis S; Chiarelli F
    Eur J Pediatr; 2011 Feb; 170(2):157-67. PubMed ID: 20556424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current therapy of polyarticular forms of juvenile idiopathic arthritis].
    Hospach A; Rühlmann JM; Weller-Heinemann F
    Z Rheumatol; 2016 Apr; 75(3):284-91. PubMed ID: 27001055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of adverse events of biologicals for treatment of juvenile idiopathic arthritis: a systematic review.
    Diener C; Horneff G
    Expert Opin Drug Saf; 2019 Aug; 18(8):719-732. PubMed ID: 31204508
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
    Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
    Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
    Horneff G
    Expert Opin Drug Saf; 2015 Jul; 14(7):1111-26. PubMed ID: 26084637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
    Foeldvari I; Becker I; Horneff G
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
    Al-Mayouf SM; Alenazi A; AlJasser H
    Int J Rheum Dis; 2016 Jun; 19(6):600-5. PubMed ID: 24730661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: a systematic review.
    Ungar WJ; Costa V; Burnett HF; Feldman BM; Laxer RM
    Semin Arthritis Rheum; 2013 Jun; 42(6):597-618. PubMed ID: 23337074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of juvenile idiopathic arthritis (JIA)].
    Takei S
    Nihon Rinsho; 2016 Jun; 74(6):1028-34. PubMed ID: 27311197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.
    Taddio A; Cattalini M; Simonini G; Cimaz R
    Expert Rev Clin Immunol; 2016 Jun; 12(6):641-9. PubMed ID: 26809126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.
    Southwood TR; Foster HE; Davidson JE; Hyrich KL; Cotter CB; Wedderburn LR; Hull RG; Venning HE; Rahman JK; Cummins CL;
    Rheumatology (Oxford); 2011 Jan; 50(1):189-95. PubMed ID: 21047801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.
    Hara R; Umebayashi H; Takei S; Okamoto N; Iwata N; Yamasaki Y; Nakagishi Y; Kizawa T; Kobayashi I; Imagawa T; Kinjo N; Amano N; Takahashi Y; Mori M; Itoh Y; Yokota S
    Pediatr Rheumatol Online J; 2019 Apr; 17(1):17. PubMed ID: 31039807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center.
    Koç R; Sönmez HE; Çakan M; Karadağ ŞG; Tanatar A; Çakmak F; Aktay Ayaz N
    Rheumatol Int; 2020 May; 40(5):771-776. PubMed ID: 31865444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of the new biologicals and cytokine antagonists in the treatment of juvenile idiopathic arthritis (JIA)].
    Horneff G
    Z Rheumatol; 2005 Jun; 64(5):317-26. PubMed ID: 15965816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biologics].
    Kalden JR
    Z Rheumatol; 2016 Aug; 75(6):604-10. PubMed ID: 27365024
    [No Abstract]   [Full Text] [Related]  

  • 17. The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data.
    Davies R; De Cock D; Kearsley-Fleet L; Southwood T; Baildam E; Beresford MW; Foster HE; Thomson W; Ramanan AV; Hyrich KL;
    Rheumatology (Oxford); 2020 Jun; 59(6):1391-1397. PubMed ID: 31605484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence.
    Gartlehner G; Hansen RA; Jonas BL; Thieda P; Lohr KN
    Clin Rheumatol; 2008 Jan; 27(1):67-76. PubMed ID: 17570009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis.
    Correll CK; Bullock DR; Cafferty RM; Vehe RK
    Clin Rheumatol; 2018 Feb; 37(2):549-553. PubMed ID: 29103180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie].
    Horneff G
    Z Rheumatol; 2006 Mar; 65(2):152-6, 158. PubMed ID: 16372138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.